When an adnexal lesion is discovered on pelvic ultrasonography, the goal of imaging is to assess if the lesion is benign or potentially malignant. Most adnexal lesions found on ultrasonography imaging are benign and can be classified as simple cysts, hemorrhagic cysts, endometriomas, and dermoids. The risk of malignancy in these lesions is extremely low.
1-9 Lesions not meeting the criteria for 1 of these 4 classic benign lesions carry an increased risk of cancer.
6,7,10-16 Multiple ultrasonography-based systems have been developed that use imaging features, such as solid tissue and vascularity, to risk stratify these lesions.
1,3,5,13,17,18 Most recently, the Ovarian-Adnexal Reporting and Data Systems (O-RADS) Committee was formed under the American College of Radiology (ACR), and this international multidisciplinary group of experts developed the O-RADS ultrasound (US) Risk Stratification and Management System. This system is based on the published lexicon of the O-RADS US working group and from data collected in the International Ovarian Tumour Analysis (IOTA) study phase 1 to phase 3 prospective studies and other studies differentiating benign from potentially malignant lesions.
1,2 The estimates for malignant neoplasm in the O-RADS US Risk Score table are based on the calculated frequency of malignant neoplasm from women undergoing surgery for known adnexal lesions in the IOTA study (Figure 1). The ACR O-RADS US committee acknowledges the limitations of applying a risk score stratification system founded on a database that includes only surgically resected lesions, which may overestimate the risk of malignant neoplasm in other populations.
2